Analyst Price Targets — VIRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 11, 2022 8:27 am | — | RBC Capital | $8.00 | $3.33 | Benzinga | RBC Capital Maintains Outperform on Viracta Therapeutics, Lowers Price Target to $8 |
No recent news available for VIRX.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VIRX.
U.S. House Trading
No House trades found for VIRX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.